| Company Name: |
Bide Pharmatech Ltd.
|
| Tel: |
400-400-164-7117 18317119277 |
| Email: |
product02@bidepharm.com |
| Products Intro: |
Product Name:tert-Butyl 3,6,9,12,15,18,21-heptaoxatetracos-23-yn-1-ylcarbamate
CAS:2112737-90-1
Purity:95% Package:100mg;250mg;1g;5g Remarks:BD00857509
|
t-Boc-N-Amido-PEG7-propargyl manufacturers
- Propargyl-PEG7-NHBoc
-
- $0.00 / 5g
-
2025-06-07
- CAS:2112737-90-1
- Min. Order: 5g
- Purity: >98.00%
- Supply Ability: 5g
|
| | t-Boc-N-Amido-PEG7-propargyl Basic information |
| Product Name: | t-Boc-N-Amido-PEG7-propargyl | | Synonyms: | t-Boc-N-Amido-PEG7-propargyl;Boc-NH-PEG7-propargyl;Propargyl-PEG7-NHBoc;tert-Butyl 3,6,9,12,15,18,21-heptaoxatetracos-23-yn-1-ylcarbamate;Propargyl-PEG8-Boc Amine;Propargyl-PEG7-NHBoc/5,8,11,14,17,20,23-Heptaoxa-2-azahexacos-25-ynoic acid, 1,1-dimethylethyl ester;5,8,11,14,17,20,23-Heptaoxa-2-azahexacos-25-ynoic acid, 1,1-dimethylethyl ester | | CAS: | 2112737-90-1 | | MF: | C22H41NO9 | | MW: | 463.56 | | EINECS: | | | Product Categories: | | | Mol File: | 2112737-90-1.mol |  |
| | t-Boc-N-Amido-PEG7-propargyl Chemical Properties |
| Boiling point | 532.7±50.0 °C(Predicted) | | density | 1.072±0.06 g/cm3(Predicted) | | storage temp. | Storage temp. 2-8°C | | form | Liquid | | pka | 12.23±0.46(Predicted) | | color | Colorless to light yellow |
| | t-Boc-N-Amido-PEG7-propargyl Usage And Synthesis |
| Description | t-Boc-N-Amido-PEG7-propargyl is a crosslinking reagent that enables the formation of triazole linkage with azides under the catalyzation of copper. The Boc-protected amine can be deprotected under mild acidic conditions. By introducing PEG chain into the molecule, the hydrophilicity can be greatly improved. | | Uses | Boc-NH-PEG7-propargyl is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. Boc-NH-PEG7-propargyl is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. | | IC 50 | PEGs | | References | [1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 DOI:10.1016/j.ebiom.2018.09.005 |
| | t-Boc-N-Amido-PEG7-propargyl Preparation Products And Raw materials |
|